N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143060 |
| CAS No | NA |
| Mol.F. | C25H33F3N4O7 |
| Mol.Wt. | 558.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143061 |
| CAS No | NA |
| Mol.F. | C20H26F3N3O6 |
| Mol.Wt. | 461.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143062 |
| CAS No | NA |
| Mol.F. | C20H24F3N3O7 |
| Mol.Wt. | 475.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143063 |
| CAS No | NA |
| Mol.F. | C23H32N4O8 |
| Mol.Wt. | 492.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143064 |
| CAS No | NA |
| Mol.F. | C8H12ClN3O2 |
| Mol.Wt. | 217.65 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143065 |
| CAS No | NA |
| Mol.F. | C14H11N5O2 |
| Mol.Wt. | 281.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143066 |
| CAS No | NA |
| Mol.F. | C22H22ClN7O2 |
| Mol.Wt. | 451.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143067 |
| CAS No | NA |
| Mol.F. | C8H10ClN3O2 |
| Mol.Wt. | 215.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143068 |
| CAS No | NA |
| Mol.F. | C14H11N5O |
| Mol.Wt. | 265.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143069 |
| CAS No | NA |
| Mol.F. | C25H28ClN7O2 |
| Mol.Wt. | 494.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143070 |
| CAS No | NA |
| Mol.F. | C41H36ClN7O2 |
| Mol.Wt. | 694.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143071 |
| CAS No | NA |
| Mol.F. | C24H24ClN7O3 |
| Mol.Wt. | 493.95 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143072 |
| CAS No | NA |
| Mol.F. | C22H20ClN7O2 |
| Mol.Wt. | 449.90 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143073 |
| CAS No | NA |
| Mol.F. | C44H43Cl2N13O2 |
| Mol.Wt. | 856.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143074 |
| CAS No | NA |
| Mol.F. | C44H43Cl2N13O2 |
| Mol.Wt. | 856.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143075 |
| CAS No | NA |
| Mol.F. | C16H13N5O3 |
| Mol.Wt. | 323.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |